טוען...
MET Exon 14 Skipping in Non-Small Cell Lung Cancer
BACKGROUND. Non-small cell lung cancers (NSCLCs) harboring specific genetic alterations can be highly sensitive to targeted therapies. MATERIALS AND METHODS. We performed a targeted rearrangement assay on 54 NSCLCs across all stages that were from patients who were never smokers and did not have dri...
שמור ב:
| הוצא לאור ב: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AlphaMed Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828128/ https://ncbi.nlm.nih.gov/pubmed/27022036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0510 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|